{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:25:10Z","timestamp":1792729510194,"version":"4.5.0"},"reference-count":184,"publisher":"Oxford University Press (OUP)","issue":"39","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic comorbidities are common in patients with cardiorenal disease; they can cause atherosclerotic cardiovascular disease (ASCVD), speed progression, and adversely affect prognosis. Common comorbidities are Type 2 diabetes mellitus (T2DM), obesity\/overweight, chronic kidney disease (CKD), and chronic liver disease. The cardiovascular system, kidneys, and liver are linked to many of the same risk factors (e.g. dyslipidaemia, hypertension, tobacco use, diabetes, and central\/truncal obesity), and shared metabolic and functional abnormalities lead to damage throughout these organs via overlapping pathophysiological pathways. The COVID-19 pandemic has further complicated the management of cardiometabolic diseases. Obesity, T2DM, CKD, and liver disease are associated with increased risk of poor outcomes of COVID-19 infection, and conversely, COVID-19 can lead to worsening of pre-existing ASCVD. The high rates of these comorbidities highlight the need to improve recognition and treatment of ASCVD in patients with obesity, insulin resistance or T2DM, chronic liver diseases, and CKD and equally, to improve recognition and treatment of these diseases in patients with ASCVD. Strategies to prevent and manage cardiometabolic diseases include lifestyle modification, pharmacotherapy, and surgery. There is a need for more programmes at the societal level to encourage a healthy diet and physical activity. Many pharmacotherapies offer mechanism-based approaches that can target multiple pathophysiological pathways across diseases. These include sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, selective mineralocorticoid receptor antagonists, and combined glucose-dependent insulinotropic peptide\/glucagon-like peptide-1 receptor agonist. Non-surgical and surgical weight loss strategies can improve cardiometabolic disorders in individuals living with obesity. New biomarkers under investigation may help in the early identification of individuals at risk and reveal new treatment targets.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehad445","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T05:45:10Z","timestamp":1689313510000},"page":"4141-4156","source":"Crossref","is-referenced-by-count":54,"title":["Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6967-5685","authenticated-orcid":false,"given":"Francesco","family":"Cosentino","sequence":"first","affiliation":[{"name":"Cardiology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital , Solna, 171 76 Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, St Michael\u2019s Hospital, Unity Health Toronto , Toronto, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ambery","sequence":"additional","affiliation":[{"name":"Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca , Gothenburg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Bach","family":"Treppendahl","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases, Global Medical Affairs, Novo Nordisk A\/S , S\u00f8borg , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"van Eickels","sequence":"additional","affiliation":[{"name":"Thrombosis & Hematology, Medical Affairs, Bayer AG , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), and German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charit\u00e9 Universit\u00e4tsmedizin , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cecchini","sequence":"additional","affiliation":[{"name":"Health Division, Organisation for Economic Co-operation and Development (OECD) , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova , Padova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-6954","authenticated-orcid":false,"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland"},{"name":"Folkh\u00e4lsan Institute of Genetics , Helsinki , Finland"},{"name":"Department of Diabetes, Monash University , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, University of Western Ontario, Robarts Research Institute , London, ON , Canada"},{"name":"Department of Pharmacology, University of Toronto, Division of Vascular Surgery, St Michael\u2019s Hospital, Unity Health Toronto , Toronto, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[{"name":"Leicester Diabetes Centre, University of Leicester , Leicester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-0018","authenticated-orcid":false,"given":"Carolyn S P","family":"Lam","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore, Duke-National University of Singapore , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Richard-Lordereau","sequence":"additional","affiliation":[{"name":"General Medicine Europe, Amgen Europe, Rotkreutz ZG , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1411-4482","authenticated-orcid":false,"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[{"name":"Karolinska Institutet and Karolinska University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-9476","authenticated-orcid":false,"given":"Paul","family":"McGreavy","sequence":"additional","affiliation":[{"name":"ESC Patients Forum , Sheffield , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N","family":"Newsome","sequence":"additional","affiliation":[{"name":"National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK"},{"name":"Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Solomon","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Weidinger","sequence":"additional","affiliation":[{"name":"2nd Medical Department with Cardiology and Intensive Care Medicine, Klinik Landstrasse , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm Clinical Investigation Center at Institut Lorrain du Coeur et des Vaisseaux, University Hospital of Nancy , Nancy , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zeiher","sequence":"additional","affiliation":[{"name":"Cardio Pulmonary Institute, Goethe University of Frankfurt , Frankfurt , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2023101419512886900_ehad445-B1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jash.2014.07.003","article-title":"Basic science: pathophysiology: the cardiorenal metabolic syndrome","volume":"8","author":"Whaley-Connell","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"2023101419512886900_ehad445-B2","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.37349\/emed.2020.00019","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin","volume":"1","author":"Acierno","year":"2020","journal-title":"Explor Med"},{"key":"2023101419512886900_ehad445-B4","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.3390\/jcm11123286","article-title":"When sugar reaches the liver: phenotypes of patients with diabetes and NAFLD","volume":"11","author":"Rojano-Toimil","year":"2022","journal-title":"J Clin Med"},{"key":"2023101419512886900_ehad445-B5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"2023101419512886900_ehad445-B6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2021.02.057","article-title":"Therapeutic manipulation of myocardial metabolism: JACC state-of-the-art review","volume":"77","author":"Honka","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40620-017-0377-y","article-title":". Obesity and kidney disease: hidden consequences of the epidemic","volume":"30","author":"Kovesdy","year":"2017","journal-title":"J Nephrol"},{"key":"2023101419512886900_ehad445-B8","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023101419512886900_ehad445-B9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/hrt.2005.086975","article-title":"Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the euro heart survey on diabetes and the heart","volume":"93","author":"Bartnik","year":"2007","journal-title":"Heart"},{"key":"2023101419512886900_ehad445-B10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12967-021-03210-9","article-title":"Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost","volume":"20","author":"Chang","year":"2022","journal-title":"J Transl Med"},{"key":"2023101419512886900_ehad445-B11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4236\/ojneph.2020.103022","article-title":"Prevalence of chronic kidney disease in patients with cardiovascular disease","volume":"10","author":"Khamis","year":"2020","journal-title":"Open J Nephrol"},{"key":"2023101419512886900_ehad445-B12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000313718","article-title":"Cardiorenal syndromes: definition and classification","volume":"164","author":"Ronco","year":"2010","journal-title":"Contrib Nephrol"},{"key":"2023101419512886900_ehad445-B13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.hjc.2017.01.003","article-title":"Diabetes and cardiorenal syndrome: understanding the \u201ctriple threat\u201d","volume":"58","author":"Banerjee","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"2023101419512886900_ehad445-B14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research","volume":"6","author":"Leon","year":"2015","journal-title":"World J Diabetes"},{"key":"2023101419512886900_ehad445-B15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2020.11.003","article-title":"Clinical outcomes in patients with heart failure hospitalized with COVID-19","volume":"9","author":"Bhatt","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2023101419512886900_ehad445-B16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.dsx.2020.06.060","article-title":"BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank","volume":"14","author":"Sattar","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2023101419512886900_ehad445-B17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003553","article-title":"Cardiometabolic risk factors for COVID-19 susceptibility and severity: a Mendelian randomization analysis","volume":"18","author":"Leong","year":"2021","journal-title":"PLoS Med"},{"key":"2023101419512886900_ehad445-B18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13679-021-00448-8","article-title":"Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care","volume":"10","author":"Sattar","year":"2021","journal-title":"Curr Obes Rep"},{"key":"2023101419512886900_ehad445-B19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41467-022-28248-1","article-title":"A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England","volume":"13","author":"Yates","year":"2022","journal-title":"Nat Commun"},{"key":"2023101419512886900_ehad445-B20","doi-asserted-by":"crossref","first-page":"m3731","DOI":"10.1136\/bmj.m3731","article-title":"Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study","volume":"371","author":"Clift","year":"2020","journal-title":"BMJ"},{"key":"2023101419512886900_ehad445-B21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2023101419512886900_ehad445-B22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2020.10.055","article-title":"Cardiovascular deaths during the COVID-19 pandemic in the United States","volume":"77","author":"Wadhera","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2023101419512886900_ehad445-B24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023101419512886900_ehad445-B25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/FJC.0000000000001364","article-title":"Efficacy and safety of finerenone for prevention of cardiovascular events in type 2 diabetes mellitus with chronic kidney disease: a meta-analysis of randomized controlled trials","volume":"81","author":"Yang","year":"2023","journal-title":"J Cardiovasc Pharmacol"},{"key":"2023101419512886900_ehad445-B26","article-title":"Efficacy and safety of finerenone in chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2023101419512886900_ehad445-B27","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(21)00591-2","article-title":"Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants","volume":"397","author":"Syn","year":"2021","journal-title":"Lancet"},{"key":"2023101419512886900_ehad445-B28","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/jama.2022.9009","article-title":"Association of bariatric surgery with cancer risk and mortality in adults with obesity","volume":"327","author":"Aminian","year":"2022","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/1753-0407.13151","article-title":"Atherosclerotic disease burden after bariatric surgery in patients with obesity and type 2 diabetes","volume":"13","author":"Ardissino","year":"2021","journal-title":"J Diabetes"},{"key":"2023101419512886900_ehad445-B30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.838027","article-title":"Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990\u20132019: results from the global burden of disease study 2019","volume":"13","author":"Safiri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023101419512886900_ehad445-B31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2023101419512886900_ehad445-B32","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"2023101419512886900_ehad445-B33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications","volume":"26","author":"Canto","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2023101419512886900_ehad445-B34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep4.1618","article-title":"Nonalcoholic fatty liver disease screening in type 2 diabetes mellitus patients in the primary care setting","volume":"5","author":"Vieira Barbosa","year":"2021","journal-title":"Hepatol Commun"},{"key":"2023101419512886900_ehad445-B35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"GBD Risk Factors Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2023101419512886900_ehad445-B36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"GBD 2015 Obesity Collaborators","year":"2017","journal-title":"N Engl J Med"},{"key":"2023101419512886900_ehad445-B37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","article-title":"Relationship between physical activity, body mass index, and risk of heart failure","volume":"69","author":"Pandey","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old","volume":"355","author":"Adams","year":"2006","journal-title":"N Engl J Med"},{"key":"2023101419512886900_ehad445-B39","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"GBD Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"key":"2023101419512886900_ehad445-B40","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/eurjpc\/zwac220","article-title":"Obesity and cardiovascular disease: beyond body weight and energy balance","volume":"29","author":"Lechner","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023101419512886900_ehad445-B41","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/eurheartj\/ehz391","article-title":"Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index","volume":"40","author":"Chen","year":"2019","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B42","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiologic targets","volume":"118","author":"Borlaug","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2023101419512886900_ehad445-B43","first-page":"413","article-title":"A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus","volume":"58","author":"Lopatynski","year":"2003","journal-title":"Ann Univ Mariae Curie Sklodowska Med"},{"key":"2023101419512886900_ehad445-B44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.archger.2016.03.021","article-title":"Performance of the waist-to-height ratio in identifying obesity and predicting non-communicable diseases in the elderly population: a systematic literature review","volume":"65","author":"Correa","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"2023101419512886900_ehad445-B45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2006-924123","article-title":"Waist\/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men\u2013a 3.6-year prospective study","volume":"114","author":"Hadaegh","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2023101419512886900_ehad445-B46","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1038\/s41598-021-87266-z","article-title":"Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance","volume":"11","author":"Lechner","year":"2021","journal-title":"Sci Rep"},{"key":"2023101419512886900_ehad445-B47","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","article-title":"Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk","volume":"71","author":"Mongraw-Chaffin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","article-title":"Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the nurses\u2019 health study): 30 year follow-up from a prospective cohort study","volume":"6","author":"Eckel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023101419512886900_ehad445-B49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"2023101419512886900_ehad445-B50","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B51","article-title":"The fatty liver assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care","volume":"2","author":"Hofmann","year":"2020","journal-title":"JHEP Rep"},{"key":"2023101419512886900_ehad445-B52","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"2023101419512886900_ehad445-B53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2020.08.005","article-title":"Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography\u2014a prospective, cross sectional study","volume":"82","author":"Mikolasevic","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2023101419512886900_ehad445-B54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B55","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/dc21-1262","article-title":"Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: a Mendelian randomization study","volume":"45","author":"Martin","year":"2022","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2023101419512886900_ehad445-B57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"2023101419512886900_ehad445-B58","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2023101419512886900_ehad445-B59","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2023101419512886900_ehad445-B60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Emerging Risk Factors Collaboration","year":"2015","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","article-title":"Diabetes with early kidney involvement may shorten life expectancy by 16 years","volume":"92","author":"Wen","year":"2017","journal-title":"Kidney Int"},{"key":"2023101419512886900_ehad445-B62","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00125-018-4700-5","article-title":"Excess risk of hospitalisation for heart failure among people with type 2 diabetes","volume":"61","author":"Rosengren","year":"2018","journal-title":"Diabetologia"},{"key":"2023101419512886900_ehad445-B63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"key":"2023101419512886900_ehad445-B64","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ki.2014.384","article-title":"Obesity, metabolic health, and the risk of end-stage renal disease","volume":"87","author":"Panwar","year":"2015","journal-title":"Kidney Int"},{"key":"2023101419512886900_ehad445-B65","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2009.03.023","article-title":"Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway","volume":"54","author":"Munkhaugen","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2023101419512886900_ehad445-B66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/clinchem\/hvab249","article-title":"Obesity and kidney function: a two-sample Mendelian randomization study","volume":"68","author":"Kjaergaard","year":"2022","journal-title":"Clin Chem"},{"key":"2023101419512886900_ehad445-B67","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.2337\/db15-0254","article-title":"Genetic evidence for a causal role of obesity in diabetic kidney disease","volume":"64","author":"Todd","year":"2015","journal-title":"Diabetes"},{"key":"2023101419512886900_ehad445-B68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2020.04.068","article-title":"Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: a blueprint for clinical trial design","volume":"313","author":"Savarese","year":"2020","journal-title":"Int J Cardiol"},{"key":"2023101419512886900_ehad445-B69","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2023101419512886900_ehad445-B70","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2019.07.065","article-title":"Incidence of, associations with and prognostic impact of worsening renal function in heart failure with different ejection fraction categories","volume":"124","author":"Lofman","year":"2019","journal-title":"Am J Cardiol"},{"key":"2023101419512886900_ehad445-B71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2023101419512886900_ehad445-B72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","article-title":"The role of adipose tissue in cardiovascular health and disease","volume":"16","author":"Oikonomou","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2023101419512886900_ehad445-B73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/met.2019.0115","article-title":"High-risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation","volume":"18","author":"Lechner","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"key":"2023101419512886900_ehad445-B74","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"2023101419512886900_ehad445-B75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmet.2019.11.018","article-title":"Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss","volume":"31","author":"Al-Mrabeh","year":"2020","journal-title":"Cell Metab"},{"key":"2023101419512886900_ehad445-B76","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","article-title":"Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the world heart federation and world obesity federation","volume":"29","author":"Lopez-Jimenez","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023101419512886900_ehad445-B77","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019\u2014cOVID-NET, 14 states, march 1\u201330, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"2023101419512886900_ehad445-B78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241824","article-title":"Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants","volume":"15","author":"Ho","year":"2020","journal-title":"PLoS One"},{"key":"2023101419512886900_ehad445-B79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms","volume":"142","author":"Sattar","year":"2020","journal-title":"Circulation"},{"key":"2023101419512886900_ehad445-B80","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/dbi20-0032","article-title":"COVID-19 and diabetes: a collision and collusion of two diseases","volume":"69","author":"Feldman","year":"2020","journal-title":"Diabetes"},{"key":"2023101419512886900_ehad445-B81","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/heartjnl-2021-320047","article-title":"Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular\/renal complications in patients with COVID-19","volume":"108","author":"Norris","year":"2022","journal-title":"Heart"},{"key":"2023101419512886900_ehad445-B82","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","article-title":"Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction","volume":"142","author":"Modin","year":"2020","journal-title":"Circulation"},{"key":"2023101419512886900_ehad445-B83","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cjca.2022.12.003","article-title":"One-year risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis","volume":"39","author":"Zuin","year":"2023","journal-title":"Can J Cardiol"},{"key":"2023101419512886900_ehad445-B84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004056","article-title":"Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: a multi-database, self-controlled case series study","volume":"19","author":"Massari","year":"2022","journal-title":"PLoS Med"},{"key":"2023101419512886900_ehad445-B85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2020.05.038","article-title":"Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic","volume":"76","author":"Bhatt","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJMc2009166","article-title":"Reduced rate of hospital admissions for ACS during COVID-19 outbreak in northern Italy","volume":"383","author":"De Filippo","year":"2020","journal-title":"N Engl J Med"},{"key":"2023101419512886900_ehad445-B87","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/eurheartj\/ehaa314","article-title":"Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage","volume":"41","author":"Metzler","year":"2020","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B88","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehaa893","article-title":"Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic","volume":"42","author":"O'Shea","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B89","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001359","article-title":"The impact of the COVID-19 pandemic on cardiology services","volume":"7","author":"Fersia","year":"2020","journal-title":"Open Heart"},{"key":"2023101419512886900_ehad445-B90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2213-8587(21)00116-9","article-title":"Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK","volume":"9","author":"Carr","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023101419512886900_ehad445-B91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41591-022-02158-7","article-title":"The impact of the COVID-19 pandemic on cardiovascular disease prevention and management","volume":"29","author":"Dale","year":"2023","journal-title":"Nat Med"},{"key":"2023101419512886900_ehad445-B92","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B93","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B94","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B95","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ehjcvp\/pvac044","article-title":"Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis","volume":"9","author":"Ferrannini","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2023101419512886900_ehad445-B97","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023101419512886900_ehad445-B98","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/ejhf.1990","article-title":"Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications","volume":"22","author":"Rey","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023101419512886900_ehad445-B99","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B100","doi-asserted-by":"crossref","first-page":"g1464","DOI":"10.1136\/bmj.g1464","article-title":"Associations between exposure to takeaway food outlets, takeaway food consumption, and body weight in cambridgeshire, UK: population based, cross sectional study","volume":"348","author":"Burgoine","year":"2014","journal-title":"BMJ"},{"key":"2023101419512886900_ehad445-B101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12916-021-01902-z","article-title":"Independent and combined associations between fast-food outlet exposure and genetic risk for obesity: a population-based, cross-sectional study in the UK","volume":"19","author":"Burgoine","year":"2021","journal-title":"BMC Med"},{"key":"2023101419512886900_ehad445-B102","author":"Davies"},{"key":"2023101419512886900_ehad445-B103","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/S1368980017003949","article-title":"Does the distribution frequency matter? A subgroup specific analysis of the effectiveness of the EU school fruit and vegetable scheme in Germany comparing twice and thrice weekly deliveries","volume":"21","author":"Hass","year":"2018","journal-title":"Public Health Nutr"},{"key":"2023101419512886900_ehad445-B104","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.3390\/ijerph182312331","article-title":"Can the school fruit and vegetable scheme be an effective strategy leading to positive changes in children's eating behaviours? Polish evaluation results","volume":"18","author":"Wolnicka","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2023101419512886900_ehad445-B105","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(16)32234-6","article-title":"New metrics for the lancet standing commission on liver disease in the UK","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"key":"2023101419512886900_ehad445-B106","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(17)32866-0","article-title":"Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the lancet standing commission on liver disease in the UK","volume":"391","author":"Williams","year":"2018","journal-title":"Lancet"},{"key":"2023101419512886900_ehad445-B107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002283","article-title":"Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: a before-and-after study","volume":"14","author":"Silver","year":"2017","journal-title":"PLoS Med"},{"key":"2023101419512886900_ehad445-B108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002326","article-title":"Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: a cost-effectiveness and equity analysis","volume":"14","author":"Lal","year":"2017","journal-title":"PLoS Med"},{"key":"2023101419512886900_ehad445-B109","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1377\/hlthaff.2016.1231","article-title":"In Mexico, evidence of sustained consumer response two years after implementing a sugar-sweetened beverage tax","volume":"36","author":"Colchero","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"2023101419512886900_ehad445-B110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15276","article-title":"Outcomes following taxation of sugar-sweetened beverages: a systematic review and meta-analysis","volume":"5","author":"Andreyeva","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023101419512886900_ehad445-B111","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/bjsports-2017-097563","article-title":"How does light-intensity physical activity associate with adult cardiometabolic health and mortality? Systematic review with meta-analysis of experimental and observational studies","volume":"53","author":"Chastin","year":"2019","journal-title":"Br J Sports Med"},{"key":"2023101419512886900_ehad445-B112","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B113","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B114","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American diabetes association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/bjsports-2017-098970","article-title":"Effects of short-term, medium-term and long-term resistance exercise training on cardiometabolic health outcomes in adults: systematic review with meta-analysis","volume":"54","author":"Ashton","year":"2020","journal-title":"Br J Sports Med"},{"key":"2023101419512886900_ehad445-B116","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.mayocpiqo.2020.09.013","article-title":"Sedentary behaviors, physical inactivity, and cardiovascular health: we better start moving!","volume":"4","author":"Carbone","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2023101419512886900_ehad445-B117","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002495","article-title":"Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis","volume":"5","author":"Wahid","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2023101419512886900_ehad445-B118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/nu11020338","article-title":"DASH Dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses","volume":"11","author":"Chiavaroli","year":"2019","journal-title":"Nutrients"},{"key":"2023101419512886900_ehad445-B119","doi-asserted-by":"crossref","first-page":"m2412","DOI":"10.1136\/bmj.m2412","article-title":"Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies","volume":"370","author":"Naghshi","year":"2020","journal-title":"BMJ"},{"key":"2023101419512886900_ehad445-B120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jhep.2019.04.013","article-title":"The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content","volume":"71","author":"Gepner","year":"2019","journal-title":"J Hepatol"},{"key":"2023101419512886900_ehad445-B121","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"key":"2023101419512886900_ehad445-B122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cmet.2018.01.005","article-title":"An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans","volume":"27","author":"Mardinoglu","year":"2018","journal-title":"Cell Metab"},{"key":"2023101419512886900_ehad445-B123","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1001\/jama.2020.17108","article-title":"Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: updated evidence report and systematic review for the US preventive services task force","volume":"324","author":"O'Connor","year":"2020","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B124","author":"Cecchini"},{"key":"2023101419512886900_ehad445-B125","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.jacc.2019.08.1016","article-title":"Preventive cardiology as a subspecialty of cardiovascular medicine: JACC council perspectives","volume":"74","author":"Shapiro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurjpc\/zwab017","article-title":"EAPC core curriculum for preventive cardiology","volume":"29","author":"Wilhelm","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023101419512886900_ehad445-B127","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2337\/dc20-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B128","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.2337\/dc20-S011","article-title":"11. Microvascular complications and foot care: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023101419512886900_ehad445-B131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573403X13666170426104611","article-title":"The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature","volume":"13","author":"Diamantis","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"2023101419512886900_ehad445-B132","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.12.051","article-title":"Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (beyond endorsed lipid lowering with EBT scanning)","volume":"61","author":"Alexopoulos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B133","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/0886022X.2021.1915799","article-title":"Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"43","author":"Zhao","year":"2021","journal-title":"Ren Fail"},{"key":"2023101419512886900_ehad445-B134","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/MJT.0000000000001499","article-title":"Statins for the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"30","author":"Dai","year":"2023","journal-title":"Am J Ther"},{"key":"2023101419512886900_ehad445-B135","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023101419512886900_ehad445-B136","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1113\/jphysiol.2014.272328","article-title":"Diabetic kidney disease: from physiology to therapeutics","volume":"592","author":"Mora-Fernandez","year":"2014","journal-title":"J Physiol"},{"key":"2023101419512886900_ehad445-B137","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc22-Sint","article-title":"Introduction: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association","year":"2022","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B138","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"2023101419512886900_ehad445-B139","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: jACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"2023101419512886900_ehad445-B141","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000518254","article-title":"Direct blood pressure-independent anti-fibrotic effects by the selective nonsteroidal mineralocorticoid receptor antagonist finerenone in progressive models of kidney fibrosis","volume":"52","author":"Droebner","year":"2021","journal-title":"Am J Nephrol"},{"key":"2023101419512886900_ehad445-B142","doi-asserted-by":"crossref","first-page":"84","DOI":"10.17925\/EE.2021.17.2.84","article-title":"Finerenone: a potential treatment for patients with chronic kidney disease and type 2 diabetes mellitus","volume":"17","author":"D'Marco","year":"2021","journal-title":"touchREV Endocrinol"},{"key":"2023101419512886900_ehad445-B143","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc08-1908","article-title":"Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study\u2014a randomized multicenter translational study","volume":"32","author":"Chan","year":"2009","journal-title":"Diabetes Care"},{"key":"2023101419512886900_ehad445-B144","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-022-01707-4","article-title":"Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis","volume":"28","author":"Sattar","year":"2022","journal-title":"Nat Med"},{"key":"2023101419512886900_ehad445-B145","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023101419512886900_ehad445-B146","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","article-title":"Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability","volume":"114","author":"Diaz-Rodriguez","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2023101419512886900_ehad445-B147","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s13300-017-0279-y","article-title":"Ipragliflozin reduces epicardial fat accumulation in non-obese type 2 diabetic patients with visceral obesity: a pilot study","volume":"8","author":"Fukuda","year":"2017","journal-title":"Diabetes Ther"},{"key":"2023101419512886900_ehad445-B148","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"2023101419512886900_ehad445-B149","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","article-title":"Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure","volume":"12","author":"Sokos","year":"2006","journal-title":"J Card Fail"},{"key":"2023101419512886900_ehad445-B150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"2023101419512886900_ehad445-B151","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/cvr\/cvaa256","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","volume":"117","author":"Withaar","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2023101419512886900_ehad445-B152","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/HYP.0000000000000202","article-title":"Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the American Heart Association","volume":"78","author":"Hall","year":"2021","journal-title":"Hypertension"},{"key":"2023101419512886900_ehad445-B153","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B154","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.2017.20813","article-title":"Lifestyle intervention and medical management with vs without roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study","volume":"319","author":"Ikramuddin","year":"2018","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B155","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery","volume":"351","author":"Sjostrom","year":"2004","journal-title":"N Engl J Med"},{"key":"2023101419512886900_ehad445-B156","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.soard.2022.02.003","article-title":"Time impact on the antidiabetic effects of key bariatric surgeries: a network meta-analysis of randomized controlled trials with meta-regression","volume":"18","author":"Sole","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"2023101419512886900_ehad445-B157","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.02250409","article-title":"Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023101419512886900_ehad445-B158","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.soard.2016.05.003","article-title":"Impact of bariatric surgery on renal functions in patients with type 2 diabetes: systematic review of randomized trials and observational studies","volume":"12","author":"Zhou","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"2023101419512886900_ehad445-B159","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41366-018-0045-x","article-title":"Incidence of end-stage renal disease following bariatric surgery in the Swedish obese subjects study","volume":"42","author":"Shulman","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"2023101419512886900_ehad445-B160","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis","volume":"326","author":"Aminian","year":"2021","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B161","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13030","article-title":"Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials","volume":"21","author":"Ding","year":"2020","journal-title":"Obes Rev"},{"key":"2023101419512886900_ehad445-B162","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s11695-018-3552-x","article-title":"Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"29","author":"Khorgami","year":"2019","journal-title":"Obes Surg"},{"key":"2023101419512886900_ehad445-B163","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/jama.2018.14619","article-title":"Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity","volume":"320","author":"Fisher","year":"2018","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B164","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sjostrom","year":"2012","journal-title":"JAMA"},{"key":"2023101419512886900_ehad445-B166","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Look Ahead Research Group","year":"2013","journal-title":"N Engl J Med"},{"key":"2023101419512886900_ehad445-B167","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","author":"Look Ahead Research Group","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023101419512886900_ehad445-B168","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S2213-8587(17)30176-6","article-title":"Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial","volume":"5","author":"Baum","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023101419512886900_ehad445-B169","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/SLA.0000000000004369","article-title":"How much weight loss is required for cardiovascular benefits? Insights from a metabolic surgery matched-cohort study","volume":"272","author":"Aminian","year":"2020","journal-title":"Ann Surg"},{"key":"2023101419512886900_ehad445-B170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7570\/jomes21033","article-title":"Next generation antiobesity medications: setmelanotide, semaglutide, tirzepatide and bimagrumab: what do they mean for clinical practice?","volume":"30","author":"Ryan","year":"2021","journal-title":"J Obes Metab Syndr"},{"key":"2023101419512886900_ehad445-B171","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/ijem.ijem_423_21","article-title":"Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: a cochrane meta-analysis","volume":"25","author":"Dutta","year":"2021","journal-title":"Indian J Endocrinol Metab"},{"key":"2023101419512886900_ehad445-B172","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","article-title":"Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation","volume":"41","author":"Mas-Peiro","year":"2020","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B173","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2023101419512886900_ehad445-B174","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"2023101419512886900_ehad445-B175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/stem.2751","article-title":"Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies","volume":"36","author":"Qadura","year":"2018","journal-title":"Stem Cells"},{"key":"2023101419512886900_ehad445-B176","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"2023101419512886900_ehad445-B177","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cmet.2019.08.015","article-title":"SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus","volume":"30","author":"Hess","year":"2019","journal-title":"Cell Metab"},{"key":"2023101419512886900_ehad445-B178","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11154-021-09669-7","article-title":"Lessons from bariatric surgery: can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?","volume":"22","author":"Bakbak","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"2023101419512886900_ehad445-B179","article-title":"Vascular risk reduction in obesity through reduced granulocyte burden and improved angiogenic monocyte content following bariatric surgery","volume":"1","author":"Hess","year":"2020","journal-title":"Cell Rep Med"},{"key":"2023101419512886900_ehad445-B180","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/eurheartj\/ehac495","article-title":"Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights from the EMPEROR program","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B181","article-title":"A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk","volume":"14","author":"Williams","year":"2022","journal-title":"Sci Transl Med"},{"key":"2023101419512886900_ehad445-B182","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B183","first-page":"716","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"43","author":"Pennells","year":"2023","journal-title":"Eur Heart J"},{"key":"2023101419512886900_ehad445-B184","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/39\/4141\/52143341\/ehad445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/39\/4141\/52143341\/ehad445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:39:53Z","timestamp":1729679993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/39\/4141\/7224026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":184,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2023,7,14]]},"published-print":{"date-parts":[[2023,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad445","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,14]]},"published":{"date-parts":[[2023,7,14]]}}}